Literature DB >> 18278180

The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses.

Akifumi Inomo1, Toshitaka Sugi, Yoshimi Fujita, Hidehiko Matsubayashi, Shun-ichiro Izumi, Mikio Mikami.   

Abstract

Recently, numerous studies have suggested an association between factor XII (FXII) deficiency and recurrent pregnancy losses, and between autoantibodies to FXII and recurrent pregnancy losses. Autoantibodies to FXII rather than FXII deficiency may be a risk factor for recurrent pregnancy losses. To know the pathogenesis of autoantibodies to FXII, epitope mapping study was done. Seventeen anti-FXII antibody positive recurrent pregnancy loss patients were chosen for this study. We used synthetic peptides in inhibition and direct binding studies to identify the antigenic binding site of autoantibodies to FXII. Among plasmas from 17 recurrent pregnancy loss patients who were positive for autoantibodies to FXII, 13 patients (76.5%) recognized amino acids 1-30, the amino-terminal heavy chain region that is known as factor XII binding site to platelet glycoprotein Ibalpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278180     DOI: 10.1160/TH07-07-0447

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

Review 1.  Autoantibodies and coagulation in reproductive medicine.

Authors:  Hidehiko Matsubayashi
Journal:  Reprod Med Biol       Date:  2009-07-18

2.  Factor XII (Hageman) levels in women with recurrent pregnancy loss.

Authors:  A Seval Ozgu-Erdinc; Cihan Togrul; Ayla Aktulay; Umran Buyukkagnici; Elif Gul Yapar Eyi; Salim Erkaya
Journal:  J Pregnancy       Date:  2014-11-12

3.  Anti-Factor XII Autoantibodies in Patients with Recurrent Pregnancy Loss Recognize the Second Epidermal Growth Factor-Like Domain.

Authors:  Yoshihiro Sato; Toshitaka Sugi; Rie Sakai
Journal:  TH Open       Date:  2019-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.